The University of Minnesota is several months into a new FDA approved trial for the treatment of dystrophic epidermolysis bullosa (EB), which is the most severe form. The Edlings hope their son Daylon, scheduled to begin treatment this month, will benefit – even though the trial itself is risky. Daylon will receive a bone marrow transplant to trigger the production of collagen VII. Of course, all of this is the “magic” of adult stem cells at work. We hope and pray the results will save Daylon’s life, and lead to the same life-saving therapies for others living with the most severe EB. See the full story here.
May 28, 2010
Adult Stem Cells still hold the best hope for EB
Leave a Comment »
No comments yet.